Oct. 22, 2025 -- Medical robotics innovator Noah Medical presented two new data sets highlighting the clinical and economic performance of the company’s Galaxy System, a next-generation Robotic-Assisted Bronchoscopy platform.

Oct. 23, 2025 — At TCT 2025, the Cardiovascular Research Foundation (CRF) announced the 2025 SET-10 (Scientific Excellence Top 10), recognizing the academic and medical institutions driving the most impactful interventional cardiovascular research.

Launched in 2023, the SET-10 honors institutions whose groundbreaking research is shaping the future of cardiovascular care and advancing the science that saves lives.

Oct. 28, 2025 — Bronchopulmonary dysplasia (BPD) is the most common — and most serious — complication of extreme prematurity. Yet clinicians still lack a reliable way to measure the severity of the disease or predict which infants will need long-term respiratory support.

Now, researchers at Children’s Hospital Los Angeles (CHLA) are investigating low-field MRI to safely capture both lung structure and function in these babies — offering a new window into how their fragile lungs develop.

Oct. 29, 2025 — FastWave Medical presented new first-in-human (FIH) and pre-clinical data for its Sola coronary laser intravascular lithotripsy (L-IVL) system at TCT 2025 (Transcatheter Cardiovascular Therapeutics) in San Francisco.

Oct. 27, 2025 — At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting in San Francisco, Royal Philips introduced its latest innovation that integrates pre-operative CT data directly into the cath lab workflow. This new capability, available through the integration of Philips’ Advanced Visualization Workspace (AVW) with the Azurion image-guided therapy system, marks a first step towards CT-guided percutaneous coronary intervention (PCI), a minimally invasive procedure to open narrowed coronary arteries and restore blood flow to the heart.

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65-85 living with moderate or greater valvular heart disease (VHD) in the United States, and at least 10.6 million with clinically significant VHD, most of whom are unaware of their condition. The prevalence of VHD increases sharply with advanced age — a finding that suggests a need for screening and treatment programs to ensure broad access to appropriate care. 

Oct. 28, 2025 — People who underwent a minimally invasive procedure to have their heart’s aortic valve replaced had similar health outcomes years after treatment as people who had surgery, Cedars-Sinai investigators and colleagues report.

Oct., 2025 — Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis, has introduced its PlaqueIQ image analysis software for the quantification and classification of plaque morphology in the carotid arteries. The first and only CT-based plaque analysis software indicated for the carotid vasculature, PlaqueIQ may help physicians diagnose carotid plaques at risk for rupture and develop patient-specific treatment pathways to prevent and monitor against ischemic stroke.

Oct. 22, 2025 – Ventric Health, a medtech innovator enabling early detection of heart failure (HF) in a primary care setting, has commenced enrollment in a large study comparing the company’s non-invasive Vivio System with the leading invasive implant to determine their respective abilities to effectively measure HF status over time and enable physicians to reduce patient hospitalizations and death.

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance performance of the Evolut transcatheter aortic valve replacement (TAVR) platform — and compatible with all commercially available TAVR systems — for patients with severe aortic stenosis.The announcement took place at the 2025 Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco, Calif.

Subscribe Now